Non-invasive Prenatal Testing industry trends, revenue, major players, growth, share and forecast to 2027

Emerging research logo

NGS technology, along with cfDNA research, has paved the way for the identification of chromosomal aberrations with increasing efficiency and reduced expense.

VANCOUVER, BC, CANADA, October 12, 2021 /EINPresswire.com/ – The global non-invasive prenatal testing market is expected to reach $ 8.75 billion by 2027, according to a new report from Emergen Research. The non-invasive prenatal test (DPNI), commonly referred to as cell-free DNA testing, is considered a significant extension of the variety of diagnostic methods used to detect fetal chromosomal abnormalities. NIPT is also considered superior to other screening modalities, especially for Down’s syndrome (one of the most common birth defects). The NIPT allows individuals to make informed decisions about whether diagnostic tests should be performed. Associated fetal chromosome abnormalities usually include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes. The report studies historical data of the Non-Invasive Prenatal Test market and offers valuable insights into key segments and sub-segments, revenue generation, demand and supply scenarios, trends, and other vital aspects.

Global Non-Invasive Prenatal Testing Market report provides comprehensive coverage of company data including details on their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial position and market position. Although NIPT is accessible in an increasing number of regions, a major commercial push should help consumer expansion in the projected years. NIPT has been confirmed by similarities to standard screening for prenatal aneuploidy and has been shown to be a beneficial screening procedure with high sensitivity and specificity. The growing popularity among pregnant women as an alternative to amniocentesis and awareness of prenatal genetic issues is leading to non-invasive prenatal testing.

With the increase in the number of pregnancies and complications, non-invasive prenatal screening is expected to become a routine procedure in the future, replacing other riskier screening procedures. NIPT has an identification sensitivity of over 99% and allows screening in less time than other forms of prenatal screening. Thus, few players offer non-invasive pregnancy monitoring. The high cost of research and intermediate diagnostic method hinders business expansion.

For Sample Copy of Global Non-Invasive Prenatal Testing Market report, visit @ https://www.emergenresearch.com/request-sample/16

NGS technology, along with cfDNA research, has paved the way for the identification of chromosomal aberrations with increasing efficiency and reduced expense. The high-risk testing industry is overcrowded and the continuing rivalry is likely to result in substantial drops in the retail price of these tests. The prevalence of such studies can be improved with reduced costs in the reproductive genetics market. The creation of new technologies for DPNI is gradually increasing due to the growing awareness of the benefits of non-invasive methods.

The report also studies the business strategies and strategic alliances undertaken by the companies to gain a solid foothold in the market. The report sheds light on mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and agreements with companies and governments. Comprehensive analysis of the competitive landscape gives readers a better understanding of the competitors.

The major competitors of the Non-Invasive Prenatal Testing Market presented in the report are:

Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI and Natera Inc., among others.
To learn more about the Global Non-Invasive Prenatal Testing Market Report, visit @ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

The report aims to provide a comprehensive understanding of the growth and expansion of the non-invasive prenatal testing market in each key region around the world. It offers accurate estimates on the expected size and growth of the market over the forecast period of 2020-2027.

Regional Analysis For Non-Invasive Prenatal Tests Market:

North America (United States, Canada)
Europe (UK, Italy, Germany, France, rest of the EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)
For the purpose of this report, Emergen Research has segmented the global non-invasive prenatal testing market on the basis of method, end use, application, and region:

Outlook Method (Revenue, Billions USD; 2017-2027)
Ultrasonic detection
Biochemical screening tests
Cell-free DNA in maternal plasma tests
Others
End-Use Outlook (Revenue, USD Billion; 2017-2027)
Diagnostic laboratories
Hospitals
Research centers
Clinics
Application Outlook (Revenue, USD Billion; 2017-2027)
Down’s syndrome
Microdeletion syndrome
Others
Market Snapshot:

The research report on the Non-invasive Prenatal Testing market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of the vital aspects of the market. Relevant data is then validated and verified by industry professionals. The report strives to provide a more in-depth overview of the overall market scenario of the non-invasive prenatal testing business sphere.

For Discount on Global Non-Invasive Prenatal Testing Market report, visit @ https://www.emergenresearch.com/request-discount/16

Contents

Chapter 1. Methodology and sources

1.1. Definition of the alopecia market

1.2. Scope of research

1.3. Methodology

1.4. Research sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid sources

1.5. Alopecia market estimation technique

Chapter 2. Executive summary

2.1. Summary overview, 2021-2028

Chapter 3. Main information

Chapter 4. Alopecia Market Segmentation and Impact Analysis

4.1. Alopecia Market Materials Segmentation Analysis

4.2. Industrial outlook

4.2.1. Analysis of alopecia market indicators

4.2.2. Alopecia Market Driver Analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Strict government regulations on carbon emissions

4.2.2.3. Increased prevalence of respiratory diseases

4.2.2.4. Growing need to improve indoor air quality

4.2.3. Analysis of the constraints of the alopecia market

4.2.3.1. High cost associated with the maintenance of Alopecia products

4.2.3.2. Availability of renewable energy sources

4.3. Technological insights

4.4. Regulatory framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive metric space analysis

4.7. Price trend analysis

4.8. Covid-19 impact assessment

Continued….

Key Benefits of Buying Global Non-Invasive Prenatal Testing Report:

Comprehensive analysis of the changing competitive landscape
Help with decision-making processes for companies as well as detailed strategic planning methodologies
Report Offers 8-Year Forecast and Assessment of Global Non-invasive Prenatal Testing Market
Help understand key product segments and their estimated growth rate
In-depth analysis of market drivers, restraints, trends and opportunities
Comprehensive regional analysis of the global non-invasive prenatal testing market
Key questions addressed in the report:

What is the growth rate of the non-invasive prenatal testing market? What is the predicted market valuation of the Non-Invasive Prenatal Testing industry by 2027?

What are the major growth and restraining factors of the non-invasive prenatal testing market?

Who are the main players operating in the market? What are the key strategies adopted by these companies?

Proceed to purchase: https://www.emergenresearch.com/select-license/16

Thanks for reading our report. If you have any customization requests for the latest report, please contact us. Our team will help you and make sure the report is tailored to your needs.

Read similar reports from Emergen Research:

Nanopharmaceutical Drugs Market @: https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market

Clinical Perinatal Software Market @: https://www.emergenresearch.com/industry-report/clinical-perinatal-software-market

Human Microbiome Modulator Market @: https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market

In Silico Drug Discovery Market @: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market

About Us:

At Emergen Research, we believe in the advancement of technology. We are a growing market research and strategy consulting company with a comprehensive knowledge base on cutting-edge and potentially disruptive technologies in the market that are expected to become more prevalent over the next decade.

Eric lee
Emerging research
+91 90210 91709
[email protected]mergenresearch.com
Visit us on social networks:
Facebook
Twitter
LinkedIn

Comments are closed.